Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Change in Cognition and Frailty After Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus (iNPH)

5. Juni 2026 aktualisiert von: Magnhild Skråmestø Dejgaard, Oslo University Hospital
The goal of this observational study is to describe changes in cognitive profile and frailty from pre shunt to one year after the shunt surgery and to identify clinical predictors of an improvement in terms of cognition and frailty during the same period. The main objective is to identify predictors of the effect on the planned shunt surgery on cognition and frailty.

Studienübersicht

Status

Abgeschlossen

Intervention / Behandlung

Detaillierte Beschreibung

Idiopathic normal pressure hydrocephalus (iNPH) is characterized by one or more of the symptoms gait disturbance, cognitive decline and urinary incontinence. The pathophysiology is not fully understood, but disturbed cerebrospinal fluid (CSF) circulation is considered one of the contributing factors. The CSF disturbance can be treated by shunt surgery with significant improvement in gait velocity and balance, whereas improvements in cognitive function are more uncertain.

Frailty is a consequence of cumulative decline in many physiological systems during a lifetime and implies an increased vulnerability to poor resolution of homoeostasis after a stressor event. Frailty is emerging as an important risk factor for mortality and postoperative complications but has to a limited degree been studied in iNPH.

We have previously, in a cross-sectional design, described cognitive profile and frailty status in patients with iNPH accepted for shunt surgery at Oslo University Hospital. The aims of this longitudinal follow-up of the same patient cohort are twofold:

  1. to describe changes in cognitive profile and frailty from pre shunt to one year after the shunt surgery, and
  2. to identify clinical predictors of an improvement in terms of cognition and frailty during the same period.

The patient sample consists of 276 patients that were accepted for shunt surgery at Oslo University Hospital in the period from September 2018 to December 2023. Their mean age was 73.1 years (range 52-85), 61% were men, and their mean length of education was 12.5 years. For the cognitive tests, we utilised z-scores (number of standard deviations (SD) from the age and education adjusted mean in a normative dataset).

For frailty, we used a 35 items Frailty Index (FI). Most of the items (frailty indicators) are scored 0 (not present) or 1 (present), while some of them have a graded score. The index is the sum score divided by the number of items, varying from 0.0 (no frailty) to 1.0 (extreme frailty). We used the same approach for assessment of the degree of frailty within each frailty domain. Cognitive decline is considered as one component of frailty. Accordingly, the Mini Mental State Examination (MMSE) is part of the FI and has a graded score. MMSE sum score <21 gives a score of 1 at this particular FI item, an MMSE score of 21-23 gives an item score of 0.7, an MMSE score of 24-26 gives an item score of 0.3, whereas an MMSE score of 27-30 does not contribute to the FI. MMSE is a screening test covering several cognitive domains. We will use MMSE to evaluate the cognitive dimension of frailty as described here, whereas more specific cognitive tests are utilised to assess failure in particular cognitive domains.

Preoperatively, the mean FI score was 0.23, and the most common frailty markers were in the domains of physical function and instrumental activities of daily living (iADL). On the group level, the iNPH patients were impaired on all cognitive domains preoperatively, but compared to patients with Alzheimer's disease, they had relatively better-preserved memory and more severe impairments in phonemic fluency.

220 (80%) patients were assessed one year postoperatively. The same cognitive tests and frailty assessments were carried out, making it possible to calculate simple change scores as score(postop) - score(preop). We will compare baseline characteristics of patients lost to follow-up descriptively with those followed, to assess potential attrition bias.

A detailed Statistical Analysis Plan (SAP) describes the planned analytical approach.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

276

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

      • Oslo, Norwegen
        • Department of Geriatric Medicine, Oslo University Hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Kind
  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

see inclusion criteria

Beschreibung

Inclusion Criteria:

• Diagnosed with iNPH and accepted for shunt surgery according to the American-European guidelines at Department of Neurosurgery, Oslo University Hospital, Rikshospitalet.

Exclusion Criteria:

  • Non-native speakers of Norwegian
  • Patients who had completed ≤ 3 cognitive tests

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Patients with idiopathic normal pressure hydrocephalus accepted for shunt surgery
Patients are already accepted for shunt surgery. We will describe changes in cognitve profile and frailty from pre shunt to one year after to identify clinical predictors for shunt response.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Trail Making Test A (TMT A) from preoperative to postoperative in patients with idiopathic normal pressure hydrocephalus (iNPH).
Zeitfenster: 12 month
TMT A is a cognitive test assessing attention and psychomotor speed and z-scores are calculated using age and educational adjusted norms. The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean. Higher z-score reflects better performance. We have defined a Minimum Clinically Important Difference (MCID) as an increase in the z-score (number of standard deviations (SD)) from the age and education adjusted mean in a normative dataset of 0.5 or more for TMT A.
12 month
Change in Frailty Index (FI) from preoperative to postoperative in patients with idiopathic normal pressure hydrocephalus (iNPH).
Zeitfenster: 12 months
For frailty, a 35 items FI was used. Most of the items (frailty indicators) are scored 0 (not present) or 1 (present), while some of them have a graded score. The index is the sum score divided by the numbers of items, varying from 0.0 (no frailty) to 1.0 (extreme frailty). We have defined a Minimum Clinically Important Difference (MCID) as a decrease in the FI of 0.05 (5 %) or more.
12 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Other measures of cognition and frailty
Zeitfenster: 12 months

Cognitive variables:

For assessing memory, delayed word recall (z score from either Consortium to Establish a Registry for Alzheimer's disease (CERAD) ten words memory test or the Rey Auditory Learning Test were used. The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean. Higher z-score reflects better performance. MCID: Z-score difference 0.5.

12 months
Other measures of cognition and frailty
Zeitfenster: 12 months
Figure Construction Test from CERAD is a cognitive test assessing visuoconstructive abilities. The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean. Higher z-score reflects better performance. MCID: Z-score difference 0.5.
12 months
Other measures of cognition and frailty
Zeitfenster: 12 months
Trail Making Test B is a cognitive test assessing attention, psychomotor speed and executive function. The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean. Higher z-score reflects better performance. MCID: Z-score difference 0.5.
12 months
Other measures of cognition and frailty
Zeitfenster: 12 months
The Phonemic Fluency Test is a cognitive test assessing language abilities and executive function. The lowest/highest possible z-score is - 3/+ 3 and indicates - 3/+ 3 SD from the mean. Higher z-score reflects better performance. MCID: Z-score difference 0.5.
12 months
Other measures of cognition and frailty
Zeitfenster: 12 months
Mini Mental State Examination (MMSE-NR3) is a cognitive screening test from 0 - 30 covering several cognitive domains. Higher score indicates better function. MMSE is part of the FI and has a graded score. MMSE sum score <21 gives a score of 1 at this particular FI item, an MMSE score of 21-23 gives an item score of 0.7, an MMSE score of 24-26 gives an item score of 0.3, whereas an MMSE score of 27-30 does not contribute to the FI. MCID: 2 points.
12 months
Other measures of cognition and frailty
Zeitfenster: 12 months
Personal activities in daily living (pADL) are subscales of the FI and are scored from 0-7, higher score indicates more need for help in daily living. An improvement is set to at least 5 % for subscale as a limit for MCID.
12 months
Other measures of cognition and frailty
Zeitfenster: 12 months
Instrumental activities in daily living (iADL) are subscales of the FI and are scored from 0-7, higher score indicates more need for help in daily living. An improvement is set to at least 5 % for subscale as a limit for MCID.
12 months
Other measures of cognition and frailty
Zeitfenster: 12 months
Gait speed (m/s) is measured from 10 m walk and 0.1 m/s or more is accepted as clinically meaningful. MCID is set to 0.1 m/s.
12 months

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Responder analysis
Zeitfenster: 12 months

Based on the MCID limits for each outcome, we will define a responder for each outcome as a patient improving that much or more from the preoperative to the one-year postoperative assessment and will calculate the percentage of responders for each of the outcomes.

We will then analyse predictors for shunt response on each of the ten outcome variables.

Candidate variables in the prediction models are:

1. Age. 2. Sex. 3. MMSE-NR3 score. 4. Gait speed. 5. FI score. 6. Difference in z-score between phonemic fluency and delayed recall at baseline. 7. Cluster affiliation (based on a previously published cluster analysis. The analytic strategy is described in detail in the Statistical Analysis Plan (SAP) that is uploaded as a separate document.

12 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. September 2018

Primärer Abschluss (Tatsächlich)

19. Juni 2025

Studienabschluss (Tatsächlich)

19. Juni 2025

Studienanmeldedaten

Zuerst eingereicht

27. Mai 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

5. Juni 2026

Zuerst gepostet (Tatsächlich)

11. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

11. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

5. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

The raw data supporting the conclsion of the article will be made available, following ethic committee guidelines on resonable request from any qualified investigators.

IPD-Sharing-Zugriffskriterien

Data sets are available from the PI on request.

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL
  • SAFT

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Ventriculoperitoneal shunt

Abonnieren